SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Medtronic (MDT) -- Ignore unavailable to you. Want to Upgrade?

To: John May who wrote (177)1/3/1998 5:11:00 PM
From: Dennis  Read Replies (1) | Respond to of 687
 
John, LIFC

Is this the company that was featured in IBD recently, They grow the skin replacement, it is not synthetic, it is real cells with NO rejection.

Dennis



To: John May who wrote (177)1/4/1998 11:53:00 AM
From: Dennis  Read Replies (1) | Respond to of 687
 
John, Lifc target

You said two analysts have a target of 14 by years end. Where did you get this info from. Thanks

Dennis



To: John May who wrote (177)1/8/1998 7:42:00 PM
From: Stuolson  Read Replies (1) | Respond to of 687
 
UBS lowered earnings estimates for MDT thrird quarter today by two cents, citing negative currency translations, delayed launch of Kappa 400 pacemaker and a sharp decline in stent sales.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News